Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001584759-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 12, 2026 |
| Document Date | Jan 8, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
13,920
Total Value
$348,280.95
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 8, 2026 | Sale | 1,620 | $25.00 | $40,500.00 | 25,545 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jan 8, 2026 | Sale | 8,015 | $25.04 | $200,655.52 | 29,392 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jan 9, 2026 | Sale | 4,285 | $25.00 | $107,125.43 | 25,107 | Indirect | See footnote | View Details |